2012年 第14卷 第8期
迈入新世纪的硼中子俘获疗法（BNCT）
中国核工业集团中原对外工程有限公司，北京 100191
下一篇 上一篇
摘要
扼要叙述进入21世纪之际，硼中子俘获疗法（boron neutorn capture therapy，BNCT）在国际范围内的一些显著进展，包括BNCT的临床定位、肿瘤复发的探索、硼浓度的定量探测、靶向掺硼药物的开发以及我国医院中子照射器的问世。这些BNCT长期开发中的瓶颈趋于缓解，预示了BNCT个性化与例行化的前景更为清晰。
图片
图1
参考文献
[ 1 ] Aris Z. BNCT:a new option against cancer(president´s address) [C]//Proceeding of 13th ICNCT. Florence, Italy,2008:5-6.
[ 2 ] Barth R F. What is the future for BNCT[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:133-137.
[ 3 ] KentJ R. Collective analysis of clinical outcomes: globally advancing BNCT[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:132.
[ 4 ] Hiroshi F, Jun-i H. BNCT for malignant melanoma and head and neck cancer: from developmental stage to clinical trial[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:68-70.
[ 5 ] Yang W, Barth B F, Wu G, et al. Molecular targeting of the epidermal growth factor receptor for BNCT of brain gliomas[R].Ohio, USA: The Ohio State University,2011.
[ 6 ] Carlsson J, Erika B K, Jacek C, et al. Ligand liposomes and BNCT[J]. Journal of Neuro-Oncology,2003,62(1/2):47-59. 链接1
[ 7 ] luligi M, Anna FC, Teresa C, et al. Boron carriers for BNCT: state of the art new perspectives deriving from nanotechnology[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:233.
京公网安备 11010502051620号
